
Normal Ovarian Reserve During Long-Term Osimertinib Therapy in a Patient With Li-Fraumeni Syndrome: A Case Report and Literature Review
<a href="https://news.google.com/rss/articles/CBMigwJBVV95cUxOOEh4TEdhQ2t3VlZvV19vbmNNVXNCU2NMTlhjeW1nTmkyYTZMQmVvQkdvVU9kRUN5TVRDMDh6ckxsYVB1TXhuSXhIeXpCSjFGYmZrQm9VTlFuTGFpWkxJQWJiREJsX2R0MGZweWRoSVRCd051cGFVOEs5WmdldE94WXFyZE8tRkZwaEN1ZlJKVExwdTlMd0d3eVBKcGlzTS1hWE96N0xtYk95UjZ5Y3g1NG00aWpCNlRFSnQtMk9IUVJVTXp6Sy11UDJ0SDJoUWxueFRsTng5cExsVndacFJpYVNIT3IzdmJ6SXVBR3NSWmg2UmpDeXhrY1lFWDJPQ3JVQ2RV?oc=5" target="_blank">Normal Ovarian Reserve During Long-Term Osimertinib Therapy in a Patient With Li-Fraumeni Syndrome: A Case Report and Literature Review</a>&nbsp;&nbsp;<font color="#6f6f6f">Cureus</font>

